Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein

Journal of Molecular Endocrinology

Volumn 30, Issue 1, 2003, Pages 31-47

  Trott, J F ^a,b   Hovey, R C ^a,b   Koduri, S ^a   Vonderhaar, B K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HORMONE BINDING PROTEIN; ISOPROTEIN; PROLACTIN; PROLACTIN RECEPTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; BREAST CANCER; CANCER CELL; CELL DIFFERENTIATION; COLORECTAL CANCER; CONTROLLED STUDY; ENDOCRINE FUNCTION; EXON; GENE AMPLIFICATION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TUMOR; LIVER TUMOR; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PANCREAS TUMOR; PARACRINE SIGNALING; PLACENTA DISORDER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; TISSUE DISTRIBUTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, NORTHERN; CARRIER PROTEINS; CELL DIFFERENTIATION; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; DNA PRIMERS; DNA, COMPLEMENTARY; EXONS; HUMANS; MOLECULAR SEQUENCE DATA; PLACENTAL LACTOGEN; PROTEIN ISOFORMS; RECEPTORS, PROLACTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0037294370     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0300031     Document Type: Review

References (49)

1. Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanat M, Kelly PA & Edery M 1997 The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter. Molecular Endocrinology 11 1449-1457.
2. Bhatavdekar JM, Patel DD, Giri DD, Karelia NH, Vora HH, Ghosh N, Shah NG, Trivedi SN & Balar DB 1992 Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum. British Journal of Cancer 66 977-980.
3. Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Ghosh N, Chikhlikar PR & Trivedi TI 2000 Prolactin as a local growth promoter in patients with breast cancer: GCRI experience. European Journal of Surgical Oncology 26 540-547.
4. Bignon C, Binart N, Ormandy CJ, Schuler LA, Kelly PA & Djiane J 1997 Long and short forms of the ovine prolactin receptor: cDNA cloning and genomic analysis reveal that the two forms arise by different alternative splicing mechanisms in ruminants and in rodents. Journal of Molecular Endocrinology 19 109-120.
5. Bignon C, Daniel N, Belair L & Djiane J 1999 In vitro expression of long and short ovine prolactin receptors: activation of Jak2/STAT5 pathway is not sufficient to account for prolactin signal transduction to the ovine beta-lactoglobulin gene promoter. Journal of Molecular Endocrinology 23 125-136.
6. Bole-Feysot C, Goffin V, Edery M, Binart N & Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Reviews 19 225-268.
7. Boutin JM, Jolicoeur C, Okamura H, Gagnon J, Edery M, Shirota M, Banville D, Dusanter-Fourt I, Djiane J & Kelly PA 1988 Cloning and expression of the rat PRL receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53 69-77.
8. Boutin JM, Edery M, Shirota M, Jolicoeur C, Lesueur L, Ali S, Gould D, Djiane J & Kelly PA 1989 Identification of a cDNA encoding a long form of PRL receptor in human hepatoma and breast cancer cells. Molecular Endocrinology 3 1455-1461.
9. Church GM & Gilbert W 1984 Genomic sequencing. PNAS 81 1991-1995.
10. Clandinin MT, Chappell JE & Mager D 1986 Prolactin binding protein in human milk. Endocrinologia Experimentalis 20 209-215.
11. Clevenger CV, Chang WP, Ngo W, Pasha TLM, Montone KTi & Tomaszewski JE 1995 Expression of prolactin and prolactin receptor in human breast carcinoma. American Journal of Pathology 146 695-705.
12. Das R & Vonderhaar BK 1995 Transduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor. Molecular Endocrinology 9 1750-1759.
13. DaSilva L, Howard OMH, Rui H, Kirken RA & Farrar WL 1994 Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. Journal of Biological Chemistry 269 18267-18270.
14. Davis JA & Linzer DIH 1989 Expression of multiple forms of the prolactin receptor in mouse liver. Molecular Endocrinology 3 674-680.
15. Edwalds-Gilbert G, Veraldi KL & Milcarek C 1997 Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Research 25 2547-2561.
16. Genty N, Paly J, Edery M, Kelly PA, Djiane J & Salesse R 1994 Endocytosis and degradation of prolactin and its receptor in Chinese hamster ovary cells stably transfected with prolactin receptor cDNA. Molecular and Cellular Endocrinology 99 221-228.
17. Ginsburg E & Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Research 55 2591-2595.
18. Goldstein B, Jones D, Kevrekidis IG & Perelson AS 1992 Evidence for p55-p75 heterodimers in the absence of IL-2 from Scatchard plot analysis. International Immunology 4 23-32.
19. Hankinson SE, Wilett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, Rosner B & Speizer FE 1999 Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute 91 629-634.
20. Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T & Miyajima A 1990 Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. PNAS 87 9655-9659.
21. Hirama T, Miller CW & Koeffler HP 1999 Translocon-associated protein alpha transcripts are induced by granulocyte-macrophage colony-stimulating factor and exhibit complex alternative polyadenylation. FEBS Letters 455 223-227.
22. Hooker AD, Green NH, Baines AJ, Bull AT, Jenkins N, Strange PG & James DC 1999 Constraints on the transport and glycosylation of recombinant IFN-gamma in Chinese hamster ovary and insect cells. Biotechnology and Bioengineering 63 559-572.
23. Hu ZZ, Zhuang L, Meng J, Leondires M & Dufau ML 1999 The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hP(N). Journal of Clinical Endocrinology and Metabolism 84 1153-1156.
24. Hu ZZ, Meng J & Dufau MLi 2001 Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. Journal of Biological Chemistry 276 41086-41094.
25. Hu ZZ, Zhuang L, Meng J, Tsai-Morris CH & Dufau ML 2002 Complex 5′ genomic structure of the human prolactin receptor: multiple alternative exons 1 and promoter utilization. Endocrinology 143 2139-2142.
26. Jabbour HN, Critchley HO & Boddy SC 1998 Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin. Journal of Clinical Endocrinology and Metabolism 83 2545-2553.
27. Kelly PA, Boutin JM, Jolicoeur C, Okamura H, Shirato M, Edery M, Dusanter-Fourt I & Djiane J 1989 Purification, cloning, and expression of the prolactin receptor. Biology of Reproduction 40 27-32.
28. Kitamura T, Hayashida K, Sakamaki K, Yokota T, Arai K & Miyajima A 1991 Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. PNAS 88 5082-5086.
29. Kline JB & Clevenger CV 2001 Identification and characterization of the prolactin-binding protein in human serum and milk. Journal of Biological Chemistry 276 24760-24766.
30. Kline JB, Roehrs H & Clevenger CV 1999 Functional characterization of the intermediate isoform of the human prolactin receptor. Journal of Biological Chemistry 274 35461-35468.
31. Laud K, Gourdou I, Belair L, Peyrat J-P & Djiane J 2000 Characterization and modulation of a prolactin receptor mRNA isoform in normal and tumoral human breast tissues. International Journal of Cancer 85 771-776.
32. Lebrun JJ, Ali S, Goffin V, Ullrich A & Kelly PA 1995 A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. PNAS 92 4031-4035.
33. Lesueur L, Edery M, Ali S, Paly J, Kelly PA & Djiane J 1991 Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. PNAS 88 824-828.
34. Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA & Goffin V 2000 Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene 19 4695-4705.
35. Maguire HC Jr & Greene MI 1989 The neu (c-erbB-2) oncogene. Seminars in Oncology 16 148-155.
36. Morrison CJ, Easton RL, Morris HR, McMaster WR, Piret JM & Dell A 2000 Modification of a recombinant GPI-anchored metalloproteinase for secretion alters the protein glycosylation. Biotechnology and Bioengineering 68 407-421.
37. Mount SM 1982 A catalogue of splice junction sequences. Nucleic Acids Research 10 459-472.
38. Nagano M, Chastre E, Choquet A, Bara J, Gespach C & Kelly PA 1995 Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract. American Journal of Physiology 268 G431-G442.
39. O'Neal KD & Yu Lee L 1994 Differential signal transduction of the short, Nb2, and long prolactin receptors. Journal of Biological Chemistry 269 26076-26082.
40. Ormandy CJ, Binart N & Kelly PA 1997 Mammary gland development in prolactin receptor knockout mice. Journal of Mammary Gland Biology and Neoplasia 2 355-364.
41. Ormandy CJ, Binart N, Helloco C & Kelly PA 1998 Mouse prolactin receptor gene: genomic organization reveals alternative promoter usage and generation of isoforms via alternative 3′-exon splicing. DNA and Cell Biology 17 761-770.
42. Patel DD, Bhatavdekar JM, Ghosh N, Vora HH, Karelia NH, Shah NG, Suthar TP, Balar DB & Trivedi CR 1994 Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator. Cancer 73 570-574.
43. Perrot-Applanat M, Gualillo O, Buteau H, Edery M & Kelly PA 1997 Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation. Journal of Cell Science 110 1123-1132.
44. Pezet A, Buteau H, Kelly PA & Edery M 1997 The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor. Molecular and Cellular Endocrinology 129 199-208.
45. Sheets MD, Ogg SC & Wickens MP 1990 Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Research 18 5799-5805.
46. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay MC, Kuttenn F et al. 1998 Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. Journal of Clinical Endocrinology and Metabolism 83 667-674.
47. Vonderhaar BK 1999 Prolactin involvement in breast cancer. Endocrine-Related Cancer 6 389-404.
48. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OGP & Tornell J 1997 Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. Journal of Clinical Investigation 100 2744-2751.
49. Yamauchi T, Yamauchi N, Ueki K, Sugiyama T, Waki H, Miki H, Tobe K, Matsuda S, Tsushima T, Yamamoto T et al. 2000 Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer. Journal of Biological Chemistry 275 33937-33944.